Evidence map›Paper›PMID 41387499›Full record

ArticleScientific reports2025

Effect of microbubble-assisted gemcitabine delivery with repeated ultrasound exposure in a pancreatic cancer organ-on-a-chip model.

Delanyo Kpeglo, Malcolm Haddrick, Margaret A Knowles, Stephen D Evans, Sally A Peyman

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Delanyo KpegloMolecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, Leeds, LS2 9JT, UK.
Malcolm HaddrickMedicines Discovery Catapult, Block 35, Mereside Alderley Park, Alderley Edge, Manchester, SK10 4TG, UK.
Margaret A KnowlesLeeds Institute of Medical Research at St James's (LIMR), School of Medicine, University of Leeds, Leeds, LS2 9JT, UK.
Stephen D EvansMolecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, Leeds, LS2 9JT, UK.
Sally A PeymanInstitute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh Campus, Edinburgh, EH14 4AS, UK. S.Peyman@hw.ac.uk.

Funding

Engineering and Physical Sciences Research Council EP/P023266/1Engineering and Physical Sciences Research Council EP/V026739/1
6 · The paper itself

Abstract

The fibrotic stroma of solid tumours poses a physical barrier to drug delivery and effective treatment. Interaction between cancerous epithelial cells and their surrounding stromal partners results in the development of a rigid, collagenous matrix environment with reduced interstitial flow, crucial for drug delivery to cancer cells, particularly in pancreatic ductal adenocarcinoma (PDAC), an aggressive pancreatic cancer with poor prognosis. Therefore, evaluating novel drug delivery mechanisms using appropriate stroma-mimicking 3D culture models is essential. We previously demonstrated, using a 21-day cultured microfluidic PDAC model that mimics the rigid, collagenous stroma, reduced interstitial flow through the tumour model. In this study, we evaluated the use of microbubbles and ultrasound as an alternative method for disrupting our model's fibrotic stroma to restore interstitial flow and improve gemcitabine delivery and efficacy. Literature shows microbubbles in 2D and 3D static cultures enhance drug delivery and effects by increasing cell membrane permeability through oscillation and bursting under ultrasound (sonoporation). Here, we observed continuous microbubble oscillation and bursting under repeated ultrasound exposure, leading to continuous matrix-microbubble and PDAC cell-microbubble interactions, which improved the gemcitabine effect. This study emphasises the need for disease-specific in vitro models to assess novel drug delivery mechanisms and improve therapeutic outcomes.

Indexed as

Antimetabolites, AntineoplasticCarcinoma, Pancreatic DuctalDeoxycytidineDrug Delivery SystemsLab-On-A-Chip DevicesMicrobubblesPancreatic NeoplasmsCell Line, TumorGemcitabineHumansMicrophysiological SystemsUltrasonic WavesAntimetabolites, AntineoplasticDeoxycytidineGemcitabineMicrobubble and ultrasound-assisted therapeutic deliveryMicrophysiological systemsOrgan-on-a-chipPancreatic ductal adenocarcinomaTumour mechanicsTumour microenvironment

Identifiers

PMID41387499
PMCPMC12715219

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.